182 related articles for article (PubMed ID: 34681866)
1. Recruitment of M1 Macrophages May Not Be Critical for Protection against Colitis-Associated Tumorigenesis.
Medina-Andrade I; Olguín JE; Guerrero-García S; Espinosa JA; Garduño-Javier E; Hernández-Gómez V; Vaca-Paniagua F; Rodríguez-Sosa M; Terrazas LI
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681866
[TBL] [Abstract][Full Text] [Related]
2. Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization.
Chen Y; Wang B; Yuan X; Lu Y; Hu J; Gao J; Lin J; Liang J; Hou S; Chen S
Phytomedicine; 2021 Mar; 83():153489. PubMed ID: 33571919
[TBL] [Abstract][Full Text] [Related]
3. EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.
Hardbower DM; Coburn LA; Asim M; Singh K; Sierra JC; Barry DP; Gobert AP; Piazuelo MB; Washington MK; Wilson KT
Oncogene; 2017 Jul; 36(27):3807-3819. PubMed ID: 28263971
[TBL] [Abstract][Full Text] [Related]
4. Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.
Singh K; Coburn LA; Asim M; Barry DP; Allaman MM; Shi C; Washington MK; Luis PB; Schneider C; Delgado AG; Piazuelo MB; Cleveland JL; Gobert AP; Wilson KT
Cancer Res; 2018 Aug; 78(15):4303-4315. PubMed ID: 29853605
[TBL] [Abstract][Full Text] [Related]
5. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
[TBL] [Abstract][Full Text] [Related]
6. The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis.
Meana C; García-Rostán G; Peña L; Lordén G; Cubero Á; Orduña A; Győrffy B; Balsinde J; Balboa MA
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232275
[TBL] [Abstract][Full Text] [Related]
7. SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment.
Dai L; Liu Y; Yin Y; Li J; Dong Z; Chen N; Cheng L; Wang H; Fang C; Lin Y; Shi G; Zhang H; Fan P; Su X; Zhang S; Yang Y; Yang L; Huang W; Zhou Z; Yu D; Deng H
J Cell Mol Med; 2020 Jan; 24(1):189-201. PubMed ID: 31578820
[TBL] [Abstract][Full Text] [Related]
8. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
Pouyet L; Roisin-Bouffay C; Clément A; Millet V; Garcia S; Chasson L; Issaly N; Rostan A; Hofman P; Naquet P; Galland F
Inflamm Bowel Dis; 2010 Jan; 16(1):96-104. PubMed ID: 19572375
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer.
Pastille E; Faßnacht T; Adamczyk A; Ngo Thi Phuong N; Buer J; Westendorf AM
Front Immunol; 2021; 12():669747. PubMed ID: 34025672
[TBL] [Abstract][Full Text] [Related]
10. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer.
Leon-Cabrera SA; Molina-Guzman E; Delgado-Ramirez YG; Vázquez-Sandoval A; Ledesma-Soto Y; Pérez-Plasencia CG; Chirino YI; Delgado-Buenrostro NL; Rodríguez-Sosa M; Vaca-Paniagua F; Ávila-Moreno F; Gutierrez-Cirlos EB; Arias-Romero LE; Terrazas LI
Cancer Immunol Res; 2017 May; 5(5):385-396. PubMed ID: 28385737
[TBL] [Abstract][Full Text] [Related]
11. Epithelial interleukin-4 receptor expression promotes colon tumor growth.
Koller FL; Hwang DG; Dozier EA; Fingleton B
Carcinogenesis; 2010 Jun; 31(6):1010-7. PubMed ID: 20176658
[TBL] [Abstract][Full Text] [Related]
12. CD16+ Macrophages Mediate Fibrosis in Inflammatory Bowel Disease.
Salvador P; Macías-Ceja DC; Gisbert-Ferrándiz L; Hernández C; Bernardo D; Alós R; Navarro-Vicente F; Esplugues JV; Ortiz-Masiá D; Barrachina MD; Calatayud S
J Crohns Colitis; 2018 Apr; 12(5):589-599. PubMed ID: 29304229
[TBL] [Abstract][Full Text] [Related]
13. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
[TBL] [Abstract][Full Text] [Related]
14. Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer.
Wu T; Dai Y; Wang W; Teng G; Jiao H; Shuai X; Zhang R; Zhao P; Qiao L
Oncotarget; 2016 Apr; 7(15):19548-58. PubMed ID: 26799669
[TBL] [Abstract][Full Text] [Related]
15. Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling.
Woo JK; Jang YS; Kang JH; Hwang JI; Seong JK; Lee SJ; Jeon S; Oh GT; Lee HY; Oh SH
Oncotarget; 2016 May; 7(20):29592-604. PubMed ID: 27127177
[TBL] [Abstract][Full Text] [Related]
16. Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.
Dai Y; Jiao H; Teng G; Wang W; Zhang R; Wang Y; Hebbard L; George J; Qiao L
Mol Cancer Ther; 2014 May; 13(5):1206-16. PubMed ID: 24651526
[TBL] [Abstract][Full Text] [Related]
17. Myeloid interleukin-4 receptor α is essential in postmyocardial infarction healing by regulating inflammation and fibrotic remodeling.
Song J; Frieler RA; Whitesall SE; Chung Y; Vigil TM; Muir LA; Ma J; Brombacher F; Goonewardena SN; Lumeng CN; Goldstein DR; Mortensen RM
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H323-H337. PubMed ID: 33164548
[TBL] [Abstract][Full Text] [Related]
18. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.
Stolfi C; Rizzo A; Franzè E; Rotondi A; Fantini MC; Sarra M; Caruso R; Monteleone I; Sileri P; Franceschilli L; Caprioli F; Ferrero S; MacDonald TT; Pallone F; Monteleone G
J Exp Med; 2011 Oct; 208(11):2279-90. PubMed ID: 21987656
[TBL] [Abstract][Full Text] [Related]
19. The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model.
Liu Y; Fang X; Yuan J; Sun Z; Li C; Li R; Li L; Zhu C; Wan R; Guo R; Jin L; Li S
Endocr Relat Cancer; 2014 Aug; 21(4):639-51. PubMed ID: 25015995
[TBL] [Abstract][Full Text] [Related]
20. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
